ArticleWorld journal of surgical oncology2023

Gastrointestinal perforation after bevacizumab: a multi-site, single-institution study with a focus on survival.

Michael H Storandt et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.